In Brief This Week: Roche; Danaher; BG Medicine; Accelr8 Technology; Waters; GenScript; Gene By Gene | GenomeWeb

NEW YORK (GenomeWeb News) – Roche said this week that it will invest CHF 240 million ($258.4 million) in a new diagnostics center at its Penzberg, Germany biotech center near Munich. The Diagnostics Operations Complex II is scheduled to be operational in December 2014 and will create 50 new jobs. Roche said the expansion is in response to "sustained global demand for the reagents used in immunoassay testing."

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Startup companies are taking on personalized medicine, CNET reports.

Bruce Booth writes at Life Sci VC that biotech clusters like Boston and San Francisco are getting even more consolidated.

The Verge speaks with Mark and Scott Kelly, who are the subjects of NASA's Twin Study.

In Genome Biology this week: genes linked to Hirschsprung disease, structural variant patterns in autism, and more.